INTEGRAL MOLECULAR
Integral Molecular is a research-driven biotechnology company creating innovative technologies and a pipeline of therapeutic antibodies
INTEGRAL MOLECULAR
Social Links:
Industry:
Biotechnology
Founded:
2001-01-01
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.integralmolecular.com
Total Employee:
11+
Status:
Active
Contact:
215-966-6061
Email Addresses:
[email protected]
Total Funding:
11.52 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Revolution BioSciences
Revolution BioSciences is an early stage drug discovery company offering CRO bioanalytical services and consulting, and MALDI MS products.
ReInnervate
ReInnervate is a biotechnology company developing enabling technologies that facilitate research into cell growth and function in vitro.
VakSea
VakSea is a biotechnology company that makes immune-boosting protein to immunize and protect shrimp from the disease.
V-Bio Ventures
V-Bio Ventures finds, builds and finances young, innovative companies with ambitions in the life sciences arena.
Medix Biochemica
Medix Biochemica Group is a global, market-leading supplier of critical raw materials to the in vitro diagnostics (IVD) industry.
MYR Pharma
MYR Pharma is a biotech company specializing in the treatment of hepatitis B and D.
Multispan
Multispan is a biotechnology company engaged in drug discovery research focused on G protein-coupled receptors (GPCRs).
O2h Ventures
Investment firm which in backing biotech, offering investors the opportunity to back promising medical innovations via the EIS and SEIS.
Lineage Cell Therapeutics
Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies to treat unmet medical needs.
argenx
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.
Antler Australia
Antler is a global early-stage VC helping build the defining companies of tomorrow by investing in the most exceptional people in Australia.
ALSA Ventures
ALSA Ventures invest in biotechnology companies passionate about bringing novel therapies to patients.
Axelar
Axelar AB is a Swedish biotechnology company that was founded in 2003 by Professor Magnus Axelson, Professor Olle Larsson and Karolinska
Aphton Corporation
Aphton Corporation biopharmaceutical company developing products using its innovative vaccine-like technology for neutralizing hormones.
Agrisera
Agrisera is a Swedish company specializing in polyclonal and monoclonal antibody production.
Aragen Bioscience
Aragen Bioscience, Inc. provides preclinical contract research and development services. The company specializes in recombinant cell line
Akron Biotechnology
Akron Biotechnology is an innovative biotechnology company focused on manufacturing high quality products for advanced therapies.
ACROBiosystems
ACROBiosystems manufactures recombinant proteins.
Altucell
Altucell is a biotech company fulfilling an"unmet need" in cell, molecular and regenerative therapy treating Diabetes.
ERS Genomics
ERS Genomics is a biotechnology company to provide broad access to the foundational CRISPR-Cas9 intellectual property.
Eppo
Eppo is a next gen AB experimentation platform that enables entrepreneurial culture.
EzBiome
EzBiome is a microbiome company empowering innovation and discovery through precision taxonomy and advanced genomic intelligence.
Bioverativ
Bioverativ is a global biotechnology company dedicated to transforming the lives of people living with hemophilia and other blood disorders.
BluMaiden Biosciences
BluMaiden Biosciences is a Platform Biotechnology Company discovering microbiome-derived disease therapeutic solutions
Beijing Northland Biotech
Beijing Northland Biotech is a R&D high-tech enterprise mainly engaged in the development of therapeutic biological products
BVF Partners
BVF Partners San Francisco-based private investment partnership specializing in fundamentally-driven public biotechnology investments
BioSavita
BioSavita's high throughput synthetic DNA technologies and yeast strains enable the rapid manufacture of fully functional antibodies,
Ferric Contrast
Ferric Contrast is a biotechnology company committed to building MRI contrast agents.
FoxKiser
FOXKISER is a company that provided strategic advice and counsel to pharmaceutical and biotechnology companies.
Fairjourney Biologics
FairJourney Biologics, a fee-for-service company, was founded in 2012 and has been profitable since 2013.
Trait Biosciences
Trait Biosciences is a cannabis biotechnology company harnessing research scientists.
Trace Matters
Trace Matters is a technology startup focused on developing next generation of mass spectrometry technologies for a variety of applications.
The Production Board (TPB)
The Production Board is a San Francisco-based investment foundry focused on improving technologies in agriculture, food and life sciences.
Telis Bioscience
Telis Bioscience is a venture-backed biotechnology firm that develops protein therapeutics.
Kite Pharma
Kite Pharma is a development-stage biotechnology company designing and developing immune-based therapies to treat cancer indications..
WRF Capital
WRF Capital supports groundbreaking research and early-stage companies that focus on life sciences and enabling technologies.
Sustainable Food Ventures
SFV backs globally early-stage founders building leading Future of Food companies that are: #Cell-based #Plant-based #Recombinant
Seegene
Seegene, Inc. is an in-vitro diagnostics (IVD) company that has been turning concepts into products through its pioneering R&D activities.
Dynamk Capital
Venture fund focused entirely on Life Sciences Industrials - tools, technologies and services fundamental to biopharma.
Dovetail Genomics
Dovetail is an early stage Santa Cruz‐based start‐up company developing cutting‐edge genomics technologies for vastly improving genome.
Drug Farm
Drug Farm is a biotechnology company utilizing genetics and AI technologies to discover and develop innovative, immune-modulating therapies.
Denovium
Denovium is an artificial intelligence company pioneering novel AI methods to accelerate innovation in biopharma.
Hemi Ventures
Hemi Ventures invests in cutting-edge technology companies in autonomous vehicles, artificial intelligence applications and biotech.
ImmunoPrecise Antibodies
ImmunoPrecise is a full-service, therapeutic antibody discovery company focused on the next generation of antibody discovery.
Inova.io
Inova is the leading provider of digital partnering solutions for the biopharma industry.
Gatehouse Bio
biotech company developing effective therapeutics using AI that harnesses the power of small RNA
greenovation Biotech
GREENOVATION Biotech, a Germany-based company, offers a platform for biopharmaceuticals to improve the activity of therapeutic proteins.
Genedant
Genedant invests in emerging life science and technology which challenge the conventional thinking of what is possible.
OMX Ventures
OMX Ventures is investing at the convergence of biology and computing.
Order-made Medical Research
Order -made Medical Research is a biotech company promoting technology development that revolutionize therapeutic antibodies.
OmniAb
Therapeutic antibody discovery
Sagimet Biosciences
Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.
Curadev Pharma Pvt. Ltd.
Curadev Pharma Pvt. Ltd. is a small molecule drug discovery biotech with an exciting portfolio of research programs
CARB-X
CARB-X is a biopharmaceutical business enterprise that specializes in biotechnology, antibiotics, vaccines, fast diagnostics.
Codexis
Codexis is a biosciences company applying synthetic chemistry technologies to create improved versions of small molecule therapeutics.
Clarify Analytical
Clarify Analytical is an innovative start-up committed to develop and provide state-of-the-art Mass Spectrometry based methodologies.
Cellerant Therapeutics
Cellerant Therapeutics is a clinical-stage company developing innovative cell- and antibody-based immunotherapies.
ProteoThera
ProteoThera, Inc. is an early stage biotechnology company that is advancing drug targeting technology.
PYC Therapeutics
PYC Therapeutics (ASX: PYC) is a development-stage biotechnology company pioneering a new generation of RNA therapeutics
Pax Momentum
Pax Momentum offers a profit-driven approach to launching innovative technology companies.
ProMab Biotechnologies Inc
ProMab helps in Generating custom, high quality monoclonal antibodies.
Current Advisors List
Current Employees Featured
Founder
Investors List
Government of Pennsylvania
Government of Pennsylvania investment in Grant - Integral Molecular
National Institute of Allergy and Infectious Diseases
National Institute of Allergy and Infectious Diseases investment in Grant - Integral Molecular
National Institute of Allergy and Infectious Diseases
National Institute of Allergy and Infectious Diseases investment in Grant - Integral Molecular
Official Site Inspections
http://www.integralmolecular.com Semrush global rank: 5.11 M Semrush visits lastest month: 1.59 K
- Host name: 180.124.174.34.bc.googleusercontent.com
- IP address: 34.174.124.180
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Integral Molecular"
Integral Molecular | Membrane Protein Experts
Integral Molecular Awarded $2.7 Million to Advance MPA Towards FDA-Qualification 11/19/2024. Integral Molecular Secures $8 Million NIAID Contract to Combat Emerging VirusesSee details»
Management Team - Integral Molecular
Meet the visionary leaders driving Integral Molecular's success. Explore our dynamic management team, comprised of industry experts and innovative thinkers shaping the future of biotechnology. Discover the faces behind our …See details»
Integral Molecular - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 215-966-6061 The objective of Integral Molecular is to create and utilize novel technologies that promote therapy discoveries against …See details»
Integral Molecular - Overview, News & Similar companies
Apr 17, 2024 Integral Molecular (www.integralmolecular.com) is the industry leader in discovering and characterizing therapeutic antibodies against membrane pro teins, an …See details»
Integral Molecular - LinkedIn
Integral Molecular is a research-driven biotechnology company specializing in antibodies, viruses, and membrane proteins. We develop technologies for solving big scientific challenges and ...See details»
Integral Molecular Breaks Ground on New …
May 24, 2022 Integral Molecular (integralmolecular.com) is the industry leader in developing and applying innovative technologies that advance the discovery of therapeutics against difficult protein targets ...See details»
SARS-CoV-2 Vaccine Immunogenicity Assays - Integral …
PPD, a global contract research organization, is among the companies that have sought an immunogenicity assay to screen patient serum samples during vaccine clinical trials. The Solution Integral Molecular’s quality-controlled SARS-CoV-2 …See details»
Integral Molecular CEO and Key Executive Team | Craft.co
Integral Molecular's VP of Research and Development is Joseph Rucker. Other executives include Sharon Willis, VP of Sales and Customer Relations; Ross Chambers, VP of Antibody …See details»
FDA Accepts Integral Molecular's Letter of Intent (LOI) on …
Sep 7, 2022 Integral Molecular (integralmolecular.com) is the industry leader in developing and applying innovative technologies that advance the discovery of therapeutics against difficult …See details»
Careers - Integral Molecular
Excellent organization and communication skills are required Demonstrated interest or experience in business is desired, but prior business experience is not required If you are interested, please send a resume and cover letter to …See details»
Integral Molecular Secures Nearly $900K in NIH Funding to …
Oct 5, 2023 Integral Molecular (integralmolecular.com) is the industry leader in developing and applying innovative technologies that advance the discovery of therapeutics against difficult …See details»
Philadelphia Biotech Integral Molecular Celebrates 20 Years of ...
Oct 12, 2021 Integral Molecular (integralmolecular.com) is the industry leader in developing and applying innovative technologies that advance the discovery of therapeutics against difficult …See details»
Use of MPA Specificity Data in Regulatory Submissions
Integral Molecular hosted the webinar “ Towards IND: Specificity Profiling of Antibody Therapies Using the Membrane Proteome Array ” on June 10, 2021. The following is the video transcript …See details»
EXPERIENCE WITH ANTIBODY SPECIFICITY SCREENING FOR IND
Integral Molecular hosted the webinar “Comprehensive Specificity Profiling of Antibody-Based Therapeutics Using the Membrane Proteome Array” on October 7, 2021. The following is the …See details»
News - Integral Molecular
Integral Molecular is a research-driven biotechnology company creating innovative technologies and therapeutic antibodies for under-exploited membrane protein targets, including GPCRs, …See details»
Integral Molecular Enters into Antibody License Agreement with ...
Nov 3, 2021 Integral Molecular (integralmolecular.com) is the industry leader in developing and applying innovative technologies that advance the discovery of therapeutics against difficult …See details»
Integral Molecular Enters Into Exclusive Antibody License With …
Jan 4, 2024 Integral Molecular (integralmolecular.com) is the industry leader in developing and applying innovative technologies that advance the discovery of therapeutics against difficult …See details»
MPS Antibody Discovery Platform: MFSD2A Case Study - Integral …
The Impact. Integral Molecular’s MPS platform successfully isolated antibodies against the complex MFSD2A transporter and provided valuable reagents to study the structure and …See details»
Publications - Integral Molecular
Integral Molecular Publications. Breaking barriers in antibody discovery: Harnessing divergent species for accessing difficult and conserved targets Banik et al. 2023 mAbs 15, 2273018; …See details»